LivaNova, headquartered inLondon, UK, is a global medical technology company formed by the merger ofSorin S.p.A. ("Sorin"), a leader in the treatment of cardiovascular diseases, and Cyberonics, a medical device company with core expertise in neuromodulation.LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The Company employs approximately 4,500 employees worldwide. With a presence in more than 100 countries,LivaNova operates as three business units: Cardiac Rhythm Management, Cardiac Surgery, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) andHouston (U.S.), respectively.
www.livanova.com
